language_icon
EN
HI

Alembic Share price

ALEMBICLTD

91.42

2.01 (-2.15%)
NSE
BSE
Last updated on 24 Apr, 2026 | 15:55 IST
Today's High

94.32

Today's Low

91.00

52 Week Low

0.00

52 Week High

94.32

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Alembic Chart

Alembic Share Key Metrics

Volume
1.36 L
Market Cap
2347.50 CR
LTQ@LTP
1@91.42
ATP
91.68
Var Margin
18.07 %
Circuit Range
74.75-112.11
Delivery %
- %
Value
1.25 CR
ASM/GSM
No
Market Lot
1

Summary

Alembic share price stands at ₹91.42 at 24 Apr, 2026 | 15:55. The stock Alembic intraday movement has stayed between ₹91.00 and ₹94.32, while on a 52-week basis it has fluctuated from ₹0.00 to ₹94.32.
In terms of trading activity, Alembic has recorded a volume of 136073 shares. The Alembic has a market cap of ₹256781828. The stock’s Average Traded Price (ATP) stands at ₹9168, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 9142.
The Alembic operates within a circuit range of ₹74.75-112.11 – ₹74.75-112.11, with a Value of ₹1.25 CR. The Delivery Percentage for the day is -1%. Additionally, Alembic currently falls under the No framework, and trades with a market lot size of 1.

Alembic Fundamentals

View More
P/E Ratio

7.39

P/B Ratio

0.92

Div. Yield

2.62

Sector P/E

70.79

Sector P/B

-15.69

Sec. Div. Yield

0.18

Alembic Resistance and Support

Pivot 93.4

Resistance

First Resistance

94.38

Second Resistance

95.32

Third Resistance

96.3

Support

First Support

92.46

Second Support

91.48

Third Support

90.54

Alembic Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

70.88%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

1.78%

Domestic Institutional Investors

0.05%

Retail

27.29%

Others

0%

Total Promoters
MAR '24
70.88%
JUN '24
70.88%
SEP '24
70.88%
DEC '24
70.88%

Alembic Corporate Actions

DateAgenda
2026-02-12Quarterly Results
2025-11-10Quarterly Results
2025-08-12Quarterly Results & Other
2025-05-13Audited Results & Final Dividend
2025-02-07Quarterly Results & Other

Alembic News

Alembic Pharma gets USFDA nod for Fingolimod capsules; targets $145 million market

Alembic Pharmaceuticals Limited has received final approval from the USFDA for its Fingolimod Capsules, 0.5 mg. This generic version of Novartis' Gilenya targets the relapsing forms of multiple sclerosis, representing an estimated US$145 million market opportunity for the 12 months ending December 2025. This approval is a significant milestone, bringing Alembic's total USFDA ANDA approvals to 237.
Apr 25 2026 12:04:00

About Alembic

NSE : 79  
BSE : 506235  
ISIN : INE426A01027  

The Company was established on 30th July 1907. Originallyit was manufacturing chemicals liquor etc. However from1950''s onwards it ventured into pharmaceutical businessin the production of bulk drugs. The Company may beconsidered as pioneer in manufacturing penicillin throughfermentation process by developing indigenous know-how. TheCompany was conferred Sir P. C. Ray award for indigenousmanufacturing of Penicillin. Over the years Company hasalso developed other bulk drugs like ErythromycinRoxithromycin and Azithromycin. The Company is also in theformulations market and is producing number of items intherapeutic segments of which some of the products are themarket leaders. The Company also gas large exports and hasalso won awards from CHEMEXIL for export performance in theyear 1991-92. It has also been recognised as Export Houseby Government of India. It is an exporter of Penicillinformulations to Germany and U.K. which are major producersof Penicillin. The Company started a Veterinary Divisionfor animal health care in 1986 and as per the ORG report(1994) they are ranked 6th in the domestic Veterinarymarket. The Company took over Neomer Limited in 1986-87which produces synthetic Fibre and yarn. Alembic Chemical''smain plant is located at Alembic Road Vadodara whichmanufactures bulk drugs and majority of the formulations.Other plant for pharmaceuticals is at Village PanelavDist. Panchmahals in Gujarat State and has modernequipment and machinery. The Company''s Neomer division hasits plant at Panelav. The company has developed schoolshospitals sports club consumer co-operative societyresidential colonies etc. The company is one of thelargest pharmaceutical companies in India and is ranked 6thin terms of pharmaceutical formulations as per (OperationsResearch Group) ORG Report of December 1995.PRESENT BUSINESS OF THE COMPANYThe Company is engaged in the manufacture of basic drugspharmaceuticals and antibiotic formulations (both for humanconsumption and animal health care). The major basic/bulkdrugs manufactured are Penicillin ErythromycinRoxithromycin and Azithromycin. The Company has thefollowing range of products:a. Bulk Drugs - These cover Penicillin ErythromycinAzithromycin Roxithromycin etc. used for formulationslike tablets capsules injectables etc.b. Antibiotic Formulations : These cover Penicillininjections and other combinations for tablets granulesointments pediatric drops etc.c. Pharmaceutical Formulations : These cover cough and coldremedies analgesics anti malarials anti-diarrhoealstonics Vitamin formulations etc.d. Other consumable products - These cover GlycodinSharkoferrol Nervitone Protinules etc.e. The Neomer Division of the Company manufactures mainlyPolypropylene Staple Fibre.

Read More

Alembic Management

NamePosition
Chirayu AminChairman
Rati DesaiNon Executive Independent Director
View More

Alembic FAQs

The Buying Price of Alembic share is 91.42 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Alembic stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Alembic shares is 7.39. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Alembic shares is 0.92. Useful to assess the stock's value relative to its book value.

To assess Alembic’s valuation compare Sector P/E, P/B which are 70.79 & -15.69 with sector averages, along with growth rates and financial metrics.

The Market Cap of Alembic is 2347.50 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Alembic share price is 94.32 & 0.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Alembic belongs to the Real Estate sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost